JAK2 and primary myelofibrosis: Other than overproduction of blood cells, the JAK2 mutation can also lead to bone marrow fibrosis, splenomegaly and increased clotting risk potentially causing deep vein thrombosis, pulmonary embolism, heart attack, and stroke.